When Akira Endo found the first cholesterol-lowering compound in 1973, he could never have predicted the significance of his discovery. The scientist’s breakthrough would lead to the creation of statin drugs, which have saved millions of lives by reducing the risk of heart disease and stroke. Fast forward to the present and a landmark study has confirmed these benefits in older populations. The research, jointly led by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Harvard TH Chan School of Public Health, addresses longstanding uncertainties about the use of statin…
